Overview
Adolescence is a critical period of neurobiological, physical, psychological, social, and cognitive transformation bridging childhood and adulthood. For the psychiatrist, mastery of normal adolescent development is essential for:
- Distinguishing normative developmental phenomena from emerging psychopathology
- Delivering developmentally calibrated clinical assessments
- Formulating appropriate, stage-specific interventions
Adolescence broadly begins with puberty and concludes with attainment of adult social, occupational, and psychological roles. No single biological or psychosocial marker precisely delineates its boundaries. Chronological age (roughly 10-24 years) is a poor proxy; developmental stage, cultural context, and individual variation all modulate the trajectory.
Epidemiology
- Approximately 20% of adolescents in Western settings have clinically significant psychological disturbance warranting intervention.
- Conversely, survey research (Offer et al.) demonstrates that approximately 80% of adolescents do not experience severe turmoil, relate well to family and peers, and transition to adulthood without major disruption, challenging the assumption that disturbance is inherent to adolescence.
- Major psychiatric disorders peaking in onset during adolescence or early adulthood: depressive disorders, anxiety disorders, schizophrenia spectrum disorders, eating disorders, and substance use disorders.
- Suicide is the second leading cause of death in young people aged 10-24 (CDC data).
Biological and Pubertal Development
Physical Changes
Puberty is initiated by activation of the hypothalamic-pituitary-gonadal (HPG) axis. Secondary sexual characteristics are staged using the Sexual Maturity Rating (SMR) system (synonymous with Tanner Stages, SMR 1-5):
- SMR 1: Prepubertal, no sexual development
- SMR 2-4: Progressive pubertal development
- SMR 5: Fully mature secondary sexual characteristics
SMR in females is based on breast development and pubic hair; in males on testicular/penile development and pubic hair. SMR correlates with, but is independent of, chronological age.
| Parameter | Females | Males |
|---|---|---|
| Body fat change | 16% → 27% by end of adolescence; lean mass falls 80% → 75% | Body fat decreases to ~12% by end of puberty |
| Weight gain (mean) | 17.5 kg (range 7-25 kg) | 23.7 kg (range 7-30 kg) |
| Peak weight gain after linear growth spurt | 3-6 months | ~3 months |
| 90% adult skeletal mass accrued by | Age 16 | Age 18 |
| Duration of puberty (average) | ~4 years | ~3 years (range 2-5 years) |
Pubertal weight gain accounts for approximately half of ideal adult body weight.
Neurodevelopment
The adolescent brain undergoes profound structural and functional reorganisation. Key concepts:
Dual System Model
The Dual System Model describes a developmental mismatch between:
- Social-emotional reactivity system (subcortical/limbic; amygdala-centred), matures earlier
- Cognitive control system (prefrontal cortex), continues maturing into mid-twenties
This mismatch underpins the increased risk-taking, sensation-seeking, and emotional reactivity characteristic of mid-adolescence (Strang, Chein & Steinberg, 2013).
Neuroimaging Findings
- Synaptic pruning and myelination are most active in the prefrontal and parietal cortex, supporting gradual maturation of executive function, planning, and impulse control.
- Functional MRI: heightened amygdala reactivity to social/emotional stimuli; diminished amygdala with increased dorsolateral PFC activation in female adolescents, suggesting earlier emotional regulatory maturity in females.
- Puberty is a period of synaptic reorganisation placing the brain in a sensitised state for development of executive functions and social cognitive skills.
- Mentalising networks become increasingly active during adolescence, supporting enhanced theory of mind and social cognition (Blakemore & Mills, 2014).
Striking Features of Adolescent Social-Emotional Development
Five cardinal features (supported by neuroimaging and developmental research):
- Increased peer group affiliation
- Striving for autonomy from parents
- Increasing capacity to mentalise (understand others' thoughts and feelings)
- Increased risk-taking behaviour
- Greater sensation-seeking
Phases of Adolescent Development
| Phase | Approximate Age | Key Developmental Features |
|---|---|---|
| Early | 10-13 years | Pubertal onset; body image preoccupation; concrete thinking; peer conformity begins; separation from parents initiated; body image vulnerability greatest |
| Middle | 14-16 years | Peak risk-taking and sensation-seeking; intense peer affiliation; abstract thinking develops; identity exploration; romantic/sexual relationships begin; enforced dependency from illness is most disruptive |
| Late | 17-21+ years | Identity consolidation; more stable relationships; future orientation; autonomy established; educational/vocational concerns predominate; return to family connectedness |
Cognitive Development
Adolescence marks the Piagetian transition from concrete operational to formal operational thinking, enabling:
- Hypothetical-deductive reasoning
- Abstract thought and metacognition
- Consideration of multiple perspectives simultaneously
- Sophisticated moral reasoning and philosophical inquiry
This cognitive maturation underpins emerging capacity for autonomous medical decision-making.
Identity Development
Erikson's psychosocial framework identifies the central adolescent task as Identity vs. Role Confusion.
Marcia's four identity statuses (elaborating Erikson):
| Status | Exploration | Commitment |
|---|---|---|
| Diffusion | Absent | Absent |
| Foreclosure | Absent | Present (adopted without exploration) |
| Moratorium | Active | Absent |
| Achievement | Completed | Present |
Key clinical points:
- Identity development is non-linear; regression is normative, especially under stress.
- The quest for identity generates heightened self-consciousness, vulnerability to shame, and reluctance to disclose distress, directly relevant to clinical engagement.
- Anna Freud observed that maintaining steady equilibrium during adolescence is itself abnormal; however, contemporary evidence (Offer et al.) clarifies that most adolescents do not experience severe turmoil, those who do warrant clinical assessment, not reassurance.
Social and Peer Development
- Early adolescence: dyadic friendships → larger peer group affiliations; popularity-focused
- Mid-adolescence: intense peer affiliation; susceptibility to peer influence on risk-taking (amplified by Dual System immaturity)
- Late adolescence: deeper, more reciprocal friendships; identity no longer dependent on single peer group conformity; romantic relationships
- Increasing mentalising capacity supports social cognition throughout
- Digital media and social platforms: pervasive contemporary influence on identity, body image, peer relationships, and self-esteem; screen for cyberbullying, online exploitation, and harmful content as routine components of assessment
Sexual Development
Sexual interest and experimentation are normative. Typical developmental sequence:
- Fantasy and masturbation (early adolescence)
- Non-penetrative genital activity with partners
- Oral sex
- Initiation of sexual intercourse (later adolescence)
In surveys (YRBSS 2018-2019), 38.4% of high school students reported sexual intercourse; at least one-third of urban adolescents reported some form of partnered genital activity in the prior year; approximately 10% reported oral sexual behaviour with a partner.
Sexual orientation and gender identity are important dimensions requiring sensitive, non-judgemental, and affirming clinical engagement.
Emotional Development: Normative Features
| Feature | Clinical Note |
|---|---|
| Heightened emotional reactivity and mood lability | Contextual and transient; not equivalent to mood disorder |
| Ambivalence about autonomy | Simultaneously seeks independence and parental security |
| Idealism alternating with self-centredness | Described by Anna Freud as normative |
| Personal fable and heightened self-consciousness | Fear of public exposure and shame; drives reluctance to disclose |
| Reluctance to share troubling feelings | Due to self-consciousness/vulnerability, not merely developmental lag |
Assessment
General Principles
- Individualise to developmental stage, not chronological age
- Conduct part of the interview with the adolescent alone to establish confidentiality and rapport
- Observe the adolescent-parent interaction
- Adopt a non-judgemental, culturally sensitive, and affirming stance
- Explore the adolescent's own perspective and the meaning they attach to their difficulties
Consultation Structure
Based on the structured adolescent consultation visit framework (Table 9-2):
| Step | Topics | With Whom |
|---|---|---|
| 1 | Visit structure; history of present illness; past and family history | Adolescent + parent(s) |
| 2 | Parental concerns; preventive guidance; confidentiality introduced | Parent(s) alone |
| 3 | Confidentiality confirmed; history including sexuality and risk behaviours | Adolescent alone |
| 4 | Physical examination (as indicated) | Adolescent (± parent per adolescent's preference) |
| 5 | Findings, recommendations; parental involvement parameters; lab notification plan; preventive guidance | Adolescent |
| 6 | Summary (as appropriate) | Adolescent + parent(s) |
HEEADSSS Psychosocial Assessment
Gold-standard structured psychosocial screening framework for adolescents:
| Domain | Focus Areas |
|---|---|
| H, Home | Living situation, family relationships, safety |
| E, Education/Employment | School performance, engagement, future plans |
| E, Eating | Body image, disordered eating, weight concerns |
| A, Activities | Recreation, exercise, hobbies, screen time |
| D, Drugs | Tobacco, alcohol, cannabis, other substances |
| S, Sexuality | Activity, orientation, gender identity, contraception, STI risk |
| S, Suicide/Depression | Mood, self-harm, suicidal ideation and intent, past attempts |
| S, Safety | Risk behaviours, violence, driving |
Confidentiality
- Confidentiality is essential: when guaranteed, adolescents are more likely to seek care, disclose sensitive information, and trust their clinician; most will involve parents voluntarily under these conditions.
- Limits must be discussed explicitly at the outset with both adolescent and family.
- Confidentiality is overridden when there is: current suicidal or homicidal intent, imminent danger to the adolescent or another person, or mandatory reporting obligations (child abuse).
- Legal definitions vary by jurisdiction; clinicians must know local law.
Indicators of Pathology vs. Normative Development
| Feature | Normal Development | Emerging Psychopathology |
|---|---|---|
| Mood lability | Transient, contextual, resolves | Persistent, pervasive, context-independent |
| Risk-taking | Episodic, peer-influenced | Escalating, solitary, high-lethality |
| Social withdrawal | Shifting peer groups, temporary | Sustained isolation, anhedonia |
| Identity exploration | Active experimentation, flexible | Rigid, highly ego-dystonic |
| Academic decline | Minor, situational | Sustained, progressive |
| Sleep changes | Circadian phase delay (normative) | Severe insomnia/hypersomnia plus other symptoms |
| Irritability | Reactive, resolves | Chronic, severe, with anhedonia |
Key clinical questions when considering whether an adolescent needs intervention:
- Has there been a developmental lapse, a falloff from prior trajectory in school, home, friendships, or activities?
- What is the level of emotional distress and its meaning to the adolescent?
- What is the range of coping skills available?
- What supports does the adolescent have from adults at home or in the community?
- Is there evidence of an emerging psychiatric disorder or positive family history?
- How impulsive is the adolescent? Is there family psychopathology or major family disruption?
- Are there concerns about physical or sexual abuse?
Validated Rating Scales
| Scale | Domain | Notes |
|---|---|---|
| HEEADSSS | Psychosocial screening | Structured interview; not scored; universal use |
| PHQ-A | Depression | 9-item; validated ≥12 years |
| GAD-7 | Anxiety | Validated in adolescent populations |
| CRAFFT | Substance use | Validated adolescent screening tool |
| Columbia Suicide Severity Rating Scale (C-SSRS) | Suicidality | Widely used across age groups |
| Children's Global Assessment Scale (CGAS) | Global functioning | Clinician-rated; 1-100 scale |
Differential Diagnosis
Disorders with important adolescent-onset presentations requiring differentiation from normal development:
- Major depressive disorder
- Bipolar disorder (type I and II)
- Anxiety disorders (social anxiety disorder, GAD, panic disorder)
- Eating disorders (anorexia nervosa, bulimia nervosa, ARFID)
- Emerging personality disorder features, ICD-11 permits personality disorder diagnosis from age 18 with appropriate developmental caveat (not recommended before 18 per ICD-11 guidance); DSM-5-TR notes personality disorder diagnosis in adolescents is possible but should be applied cautiously and only if features have been present for at least 1 year (except ASPD, which requires age ≥18)
- Substance use disorders (DSM-5-TR severity specifiers: mild/moderate/severe)
- Psychotic disorders (schizophrenia, brief psychotic disorder)
- ADHD (often presenting or re-presenting in adolescence with increased executive demands)
- Cannabis use disorder (particularly relevant given prevalence and neurodevelopmental vulnerability)
Management
Engagement and Therapeutic Alliance
Rapport-building is the cornerstone of adolescent psychiatric treatment. Practical strategies:
- Begin by exploring non-clinical topics (friends, hobbies, school) to establish alliance
- Demonstrate sensitivity to developmental stage, sexual orientation, gender identity, and cultural background
- Respect the adolescent's growing need for independence and to be treated as an individual
- Explore the adolescent's perspective before seeking parental input
Consent, Assent, and Legal Framework
- Gillick competence (reflected in Australian common law): adolescents may consent to treatment if they demonstrate sufficient maturity and understanding, a functional, not age-based, assessment
- Assent: even when parental consent is legally required, seeking the adolescent's genuine agreement is ethically important and clinically effective
- Parents must provide informed consent for most treatments in those under 18; exceptions exist (emergency, emancipated minors, jurisdiction-specific provisions)
- Involuntary treatment governed by state/territory Mental Health Acts (e.g. Mental Health Act 2014 [Vic], Mental Health and Wellbeing Act 2022 [Vic], Mental Health Act 2016 [Qld], Mental Health Act 2007 [NSW]) with additional procedural safeguards for minors
- Treatment against an adolescent's will is reserved for extreme circumstances (severe psychosis, dangerous suicidality)
Pharmacological Interventions
Reserved for diagnosed psychiatric conditions, not developmental disturbance per se. Principles:
- Start at lower doses; titrate carefully
- Monitor for adverse effects: suicidality (antidepressants, black box warning; particularly monitor in first weeks), metabolic effects (antipsychotics), growth suppression (stimulants), sexual dysfunction (SSRIs, discuss privately with adolescent)
- Discuss risks and benefits with both adolescent and parent; document assent
| Drug Class | Agent(s) | Indication | Notes |
|---|---|---|---|
| SSRI | Fluoxetine, sertraline | Depression, anxiety | Fluoxetine has strongest adolescent evidence base; TGA/NICE-supported |
| Stimulant | Methylphenidate, mixed amphetamine salts | ADHD | Monitor growth, cardiovascular parameters |
| Atypical antipsychotic | Risperidone, olanzapine, aripiprazole | Psychosis, bipolar disorder | Metabolic monitoring essential |
| Mood stabiliser | Lithium, valproate, lamotrigine | Bipolar disorder | Valproate, teratogenicity counselling in females |
Psychological Interventions
| Intervention | Primary Indication(s) | Evidence Base |
|---|---|---|
| Cognitive Behavioural Therapy (CBT) | Depression, anxiety, eating disorders | Strong; adapt to developmental stage |
| Dialectical Behaviour Therapy, Adolescent (DBT-A) | Emotion dysregulation, self-harm, borderline features | Strong |
| Family-Based Treatment (FBT/Maudsley) | Anorexia nervosa | Preferred first-line for adolescent AN |
| Interpersonal Therapy for Adolescents (IPT-A) | Depression | Evidence-based; targets developmental interpersonal themes |
| Motivational Interviewing (MI) | Substance use, treatment engagement | Effective in adolescent populations |
| Multisystemic Therapy (MST) | Conduct disorder, antisocial behaviour | Integrates home, school, and community; evidence-based |
Social and Systems-Level Interventions
- School liaison: psychoeducation for teachers; classroom adjustments; school wellbeing support; small interventions (e.g. classroom change) can be highly effective
- Family psychoeducation and family therapy
- Community mental health: headspace (Australia), Orygen-affiliated services, Te Pou (NZ)
- Digital/online mental health resources (increasing evidence base)
- Vocational support for older adolescents
Special Populations
Adolescents with Chronic Physical Illness
Chronic illness disrupts normal developmental tasks differentially by phase:
| Phase | Key Developmental Challenge |
|---|---|
| Early adolescence | Distorted body image; isolation from peers |
| Middle adolescence | Enforced dependency; decreased peer acceptance |
| Late adolescence | Educational/vocational impairment; concerns about relationships, marriage, and future |
Management principles:
- Treat the "adolescent with [condition]", not the condition as the adolescent's defining identity
- Encourage self-care autonomy and self-reliance
- Minimise unnecessary medical intrusiveness and procedures
- Provide honest, understandable information; acknowledge uncertainty without withholding prognosis
- Address parental overprotectiveness; avoid conspiracy of silence with dying adolescents
- The more visible a condition, paradoxically, the less the psychological suffering; invisible conditions (e.g. epilepsy) carry greater stigma burden
- Fluctuating/unpredictable illness course is more distressing than stable or predictable trajectories
Gender and Sexually Diverse Adolescents
LGBTQIA+ adolescents experience elevated rates of depression, anxiety, self-harm, and suicidality, primarily attributable to minority stress, family rejection, and social stigma. Clinical assessment must be affirming, non-judgemental, and consistent with RANZCP Position Statements on LGBTQIA+ mental health.
First Nations Adolescents (Australia and New Zealand)
Aboriginal, Torres Strait Islander, and Māori adolescents require culturally safe, community-informed, and trauma-informed approaches. The profound developmental impacts of historical trauma, systemic racism, housing instability, and community disruption must be explicitly recognised. Refer to RANZCP Position Statements on Indigenous mental health and, in NZ, Te Tiriti o Waitangi obligations.
Prognosis
Most adolescents navigate the developmental period successfully without lasting psychological morbidity. Early identification and appropriate intervention substantially improve outcomes for those with emerging mental illness.
| Protective Factors | Risk Factors |
|---|---|
| Strong family relationships | History of trauma or abuse |
| Supportive peer networks | Family psychopathology |
| Academic engagement | Substance use |
| Good coping repertoire | Diagnosable psychiatric disorder |
| Community connectedness | Social isolation, bullying, cyberbullying |
| Cultural identity and belonging | Minority stress (LGBTQIA+, First Nations) |
High-Yield Examination Summary
- 80% of adolescents do not experience severe turmoil; 20% require clinical intervention
- SMR (Tanner Stages) 1-5; SMR is independent of chronological age
- Dual System Model: limbic > prefrontal maturation → risk-taking, emotional reactivity
- HEEADSSS: H-E-E-A-D-S-S-S (Home, Education, Eating, Activities, Drugs, Sexuality, Suicide/Depression, Safety)
- Erikson: Identity vs. Role Confusion; Marcia: diffusion/foreclosure/moratorium/achievement
- Confidentiality is overridden by suicidal/homicidal intent, imminent danger, mandatory reporting
- Gillick competence: functional capacity assessment, not age-based
- Fluoxetine: strongest adolescent antidepressant evidence; black box warning for suicidality applies to all antidepressants in under-25s
- MST: evidence-based for conduct disorder; integrates school, home, community, office
- DBT-A: evidence-based for adolescent emotion dysregulation and self-harm
- FBT (Maudsley): preferred first-line for adolescent anorexia nervosa
- Suicide: second leading cause of death in adolescents aged 10-24
Sources